A DHT blocker is any substance that reduces levels of dihydrotestosterone, a potent hormone responsible for hair loss and prostate growth. These blockers work by interfering with the enzyme that converts testosterone into DHT, and they come in both prescription and natural forms. They’re most commonly used to treat male pattern baldness and enlarged prostate.
How Your Body Makes DHT
Testosterone on its own is a relatively mild hormone in certain tissues. It becomes far more powerful when an enzyme called 5-alpha reductase converts it into dihydrotestosterone. DHT binds to hormone receptors several times more strongly than testosterone does, which is why it has such outsized effects on hair follicles and prostate tissue.
Your body has two versions of the 5-alpha reductase enzyme. Type 2 is the dominant form in prostate tissue and hair follicles, which is why it’s the primary target of most DHT-blocking treatments. Type 1 is found more broadly across the body, including in the skin and liver. There’s also a lesser-known production pathway: your body can produce DHT from other hormonal precursors without ever making testosterone as an intermediate step. This alternate route, which runs through a compound called androstanedione, helps explain why DHT can be difficult to suppress completely.
Prescription DHT Blockers
Two prescription medications currently block 5-alpha reductase. Finasteride targets only the Type 2 enzyme, while dutasteride inhibits both Type 1 and Type 2. That difference in coverage translates directly into how much DHT each drug suppresses. In a head-to-head comparison after 24 weeks, dutasteride reduced serum DHT by 95%, compared to 71% for finasteride.
For hair loss, finasteride at a low dose reduces DHT in scalp tissue by roughly 64% and in the bloodstream by about 71%. That’s enough to slow or stop hair miniaturization in the majority of men. For enlarged prostate, higher doses are used, and the effects on prostate size are substantial: one study found that 36 months of treatment reduced prostate volume by 27% from baseline, while untreated prostates continued to grow.
European and American urology guidelines recommend these medications specifically for men with moderate to severe urinary symptoms and measurably enlarged prostates (over 40 grams). They’re not recommended for men without actual prostate enlargement.
Topical vs. Oral Formulations
Topical finasteride applied directly to the scalp produces similar hair growth results to the oral version but with dramatically lower systemic exposure. Peak blood levels of the drug are more than 100 times lower with the topical spray, and serum DHT drops by about 34.5% compared to 55.6% with oral finasteride. That reduced systemic impact is the main appeal: you get localized DHT suppression at the follicle with less effect on the rest of your body.
Side Effects and Risks
Sexual side effects are the primary concern with prescription DHT blockers. Across clinical trials, the reported rates for finasteride break down as follows: erection difficulties in 4.9% to 15.8% of users, reduced sex drive in 3.1% to 5.4%, and ejaculatory changes in 2.1% to 7.7%. A longer-term study found that these effects occurred in fewer than 2% of men, and by the fifth year of treatment, the incidence of each side effect had dropped to 0.3% or lower.
A more controversial concern is something called Post-Finasteride Syndrome, where sexual, cognitive, and psychological symptoms reportedly persist after stopping the drug. Reported symptoms include lasting erectile dysfunction, loss of libido, cognitive impairment, depression, and muscle changes. The condition is not formally recognized by the medical community, and existing studies are too low in quality to confirm or rule it out as a distinct condition. Still, the volume of patient reports has prompted ongoing investigation.
Natural DHT Blockers
Saw palmetto is the most studied natural DHT blocker. It’s a plant extract thought to work through a similar mechanism as prescription drugs, partially inhibiting 5-alpha reductase. The largest randomized trial to date compared 320 mg of saw palmetto daily against finasteride in 100 men over two years. Finasteride was clearly superior: 68% of finasteride users had improved hair density versus 38% in the saw palmetto group. However, saw palmetto did stabilize hair loss progression in 52% of cases, making it a partial option for those who want to avoid prescription medication.
Topical caffeine is another option that works through a different mechanism entirely. Rather than blocking DHT production, caffeine promotes cell activity in hair follicles by boosting a signaling molecule involved in cell growth. In lab studies, caffeine reversed testosterone-induced suppression of hair follicle growth at concentrations as low as 0.001%. It also counteracted one of the key growth-inhibiting signals that DHT triggers in male hair follicles. While promising in vitro, caffeine’s real-world effects are milder than prescription blockers.
How Long DHT Blockers Take to Work
DHT blockers are not fast-acting when it comes to visible results. The biochemical changes begin within days of starting treatment, as DHT levels in the blood and scalp tissue drop. But hair follicles operate on slow growth cycles, and reversing miniaturization takes time. Most people begin to notice changes in hair volume and thickness within the first few months to a year of consistent use.
The initial months can be misleading. Some users experience a temporary increase in shedding as weakened hairs are pushed out by new growth. Stabilization of hair loss, meaning you stop losing more ground, typically happens before any visible regrowth. Because of these timelines, most dermatologists evaluate effectiveness at the 12-month mark rather than expecting earlier results.
For prostate-related use, symptom relief and measurable prostate shrinkage also develop gradually over months, with studies typically assessing outcomes at six months to a year. Combining a DHT blocker with other prostate medications can produce faster symptom improvement while waiting for the prostate tissue to shrink.